Generating Big Revenue Growth

Today we are issuing an updated research report on a NASDAQ stock that appears poised to move much higher. Here's why:

  • The Company enjoyed over 300% revenue growth in its most recent quarter.
  • The CEO just bought 100,000 shares last week and may buy more.
  • An acquisition in August should be a major revenue contributor.
  • The stock should benefit from a huge day on Friday for its industry leader that released string Q3 results.
New Research Update

Today we are releasing an update on a stock under coverage that has made major strides to increase the company's overall value. Not only is it primed to rise based on future sales and developmental milestones but it is a great alternative to the traditional equities that have been getting smacked the past couple of weeks.

Diverse, Innovative Energy Player Offers Greatest Upside in the Space

We originally initiated coverage of today’s featured stock in 2012. It has risen by more than 500% since then and we expect similar returns going forward. This innovative company is set to introduce what may be the most disruptive technology in the chemical and energy industries in years, with target markets representing tens of billions of dollars.

With key milestones ahead, deep IP, and innovative offerings that could serve as better alternatives to existing products and processes, this stock has the wind at its back. Moreover, its joint ventures with Fortune 100 companies validate and confirm the huge inherent potential in these shares.

Top Pure Play

Today we are initiating coverage of a stock that trades at an incredibly low valuation for a revenue generating company with potentially high margins and with multiple shots on goal. Plus, this relative unknown is the only pure play of its kind.

As management continues to successfully execute its business model, the overall value of the company should rise dramatically, resulting in substantial stock accumulation.

New Trade Alert
Since our last trade alert on this NASDAQ company the stock reached a peak return of 12%. Looking ahead, the current, early stages of a short squeeze, new contract news, and a higher valuation for a key peer mean that this stock is primed to jump 20-25% from current levels in the near term. Yesterday, the Company announced a new, large scale contract, and, with a series of major LOIs, bids and trials to its credit, investors can expect more seven figure deals ahead. Interestingly, one if its peers also announced a big contract yesterday and the stock jumped 40%. See why we believe that this stock is the next one to move.
A 300% Gainer Moving Higher

On the heels of our NFL theme yesterday, we are featuring a stock this morning that will likely resonate with many readers.

I am sure that fans all across the country were drinking beer and having a great time while watching the full slate of games, yesterday. Unfortunately, some of these fans have a serious problem with alcoholism and addiction to harmful substances.

The good news is that we are once again featuring a company that has designed what may be the holy grail of alcohol treatment. The Company’s program is so popular that it has already seen a 300% increase in enrollees in the past year, with even higher growth figures in the offing, as more clinics open around the country.

This Stock is a Three-Bagger

One of our favorite Opportunity Research (sponsored) companies released results last week and sales grew by 252% from last year to $14.1M with operating income increasing by 345%. The growth is outrageous which is why we believe it is an easy three-bagger.

New Trade Alert

We are issuing a trade alert on a NASDAQ company we have followed since 2011 that not only is primed to move much higher on the heels of M&A, but could be aided by the near term commencement of a short squeeze.

Fundamentally, company revenue could reach the $14M - $16M range this year, up from a few hundred thousand in 2013 and could achieve $25M+ in revenue next year, aided by recently closed and pending M&A. The stock, which has been the target of naked short selling, is primed to be driven to new levels by short covering in response to pending events, taking the fast-growing company to new highs.

Stock Could Triple on Higher Valuation

Today we are initiating coverage of a company that might be the perfect answer to a market correction, given its industry and asset class. At its peak, the stock carried a market cap of $200M. Today the dual-listed stock is a fraction of that level yet the model is better than ever. That is why we are projecting a triple from current levels.

This Upstart Has Industry-Leading Gross Margins

I am usually not a fan of sub-penny stocks given the inherent risk they pose. In the case of today’s profiled stock, I was compelled to make an exception. After all, the Company was profitable and posted $3.6 million in sales last year (up from $2.3M in 2010) and has a much higher gross margin than any of its competitors, including the publicly traded industry leader. It doesn’t hurt that its extremely low valuation of .3x its 2013 sales means it has room to move higher and could get a boost from the execution of its own M&A down the road.

<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 11 of 36